Our Mission is to advance the science related to the diagnosis, treatment and prevention of desmoid tumors by:
- Increasing funding and support of research into the biological mechanisms and clinical strategies related to the diagnosis, treatment and prevention of desmoids tumors
- Facilitating and enhancing the dialog among members of the medical and scientific communities about basic and clinical research efforts that relate to desmoid tumors.
- Heightening the public's awareness of desmoid diagnosis and treatment and providing informational support for patients, their families and friends.
Feel free to reach out to us at [email protected] with any questions.
Marlene Portnoy, Co-Founder and Executive Director
Jeanne Whiting, Co-Founder and President
Overview
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 4, 2022 | The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform | ATLANTA (PRWEB) February 04, 2022 In honor of World Cancer Day on February 4th, The Desmoid Tumor Research Foundation (DTRF) is celebrating the success of The DTRF Virtual Tumor Board program in closing care gaps and patient access barriers... |
Reviews 0
FAQ about DTRF
When was DTRF founded?
DTRF was founded in 2005.
What has the press written about DTRF?
Parsers VC has collected 2 articles mentioning DTRF, among them “The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform” (Feb 4, 2022).
Is DTRF still active?
Yes, DTRF is active; its latest activity on Parsers VC dates from Oct 26, 2022.